Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Yersinia pseudotuberculosis disrupts intestinal barrier integrity through hematopoietic TLR-2 signaling.

Jung C, Meinzer U, Montcuquet N, Thachil E, Château D, Thiébaut R, Roy M, Alnabhani Z, Berrebi D, Dussaillant M, Pedruzzi E, Thenet S, Cerf-Bensussan N, Hugot JP, Barreau F.

J Clin Invest. 2012 Jun;122(6):2239-51. doi: 10.1172/JCI58147. Epub 2012 May 8.

2.

Toll-like receptor 2 is critical for induction of Reg3 beta expression and intestinal clearance of Yersinia pseudotuberculosis.

Dessein R, Gironella M, Vignal C, Peyrin-Biroulet L, Sokol H, Secher T, Lacas-Gervais S, Gratadoux JJ, Lafont F, Dagorn JC, Ryffel B, Akira S, Langella P, Nùñez G, Sirard JC, Iovanna J, Simonet M, Chamaillard M.

Gut. 2009 Jun;58(6):771-6. doi: 10.1136/gut.2008.168443. Epub 2009 Jan 27.

PMID:
19174417
3.

A Yersinia effector with enhanced inhibitory activity on the NF-κB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages.

Zheng Y, Lilo S, Brodsky IE, Zhang Y, Medzhitov R, Marcu KB, Bliska JB.

PLoS Pathog. 2011 Apr;7(4):e1002026. doi: 10.1371/journal.ppat.1002026. Epub 2011 Apr 21.

4.

Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction.

Meinzer U, Barreau F, Esmiol-Welterlin S, Jung C, Villard C, Léger T, Ben-Mkaddem S, Berrebi D, Dussaillant M, Alnabhani Z, Roy M, Bonacorsi S, Wolf-Watz H, Perroy J, Ollendorff V, Hugot JP.

Cell Host Microbe. 2012 Apr 19;11(4):337-51. doi: 10.1016/j.chom.2012.02.009.

5.

IscR is essential for yersinia pseudotuberculosis type III secretion and virulence.

Miller HK, Kwuan L, Schwiesow L, Bernick DL, Mettert E, Ramirez HA, Ragle JM, Chan PP, Kiley PJ, Lowe TM, Auerbuch V.

PLoS Pathog. 2014 Jun 12;10(6):e1004194. doi: 10.1371/journal.ppat.1004194. eCollection 2014 Jun.

6.

Analysis of the role of invasin during Yersinia pseudotuberculosis infection of mice.

Marra A, Isberg RR.

Ann N Y Acad Sci. 1996 Oct 25;797:290-2. No abstract available.

PMID:
8993384
8.

Nod2 mediates susceptibility to Yersinia pseudotuberculosis in mice.

Meinzer U, Esmiol-Welterlin S, Barreau F, Berrebi D, Dussaillant M, Bonacorsi S, Chareyre F, Niwa-Kawakita M, Alberti C, Sterkers G, Villard C, Lesuffleur T, Peuchmaur M, Karin M, Eckmann L, Giovannini M, Ollendorff V, Wolf-Watz H, Hugot JP.

PLoS One. 2008 Jul 23;3(7):e2769. doi: 10.1371/journal.pone.0002769.

9.

Immune response to diphtheria toxin-mediated depletion complicates the use of the CD11c-DTR(tg) model for studies of bacterial gastrointestinal infections.

Westermark L, Fahlgren A, Fällman M.

Microb Pathog. 2012 Sep;53(3-4):154-61. doi: 10.1016/j.micpath.2012.06.004. Epub 2012 Jul 6.

PMID:
22771374
10.

Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22.

Porte R, Van Maele L, Muñoz-Wolf N, Foligné B, Dumoutier L, Tabareau J, Cayet D, Gosset P, Jonckheere N, Van Seuningen I, Chabalgoity JA, Simonet M, Lamkanfi M, Renauld JC, Sirard JC, Carnoy C.

Infect Immun. 2017 Jan 26;85(2). pii: e00806-16. doi: 10.1128/IAI.00806-16. Print 2017 Feb.

11.

Pseudomonas fluorescens alters the intestinal barrier function by modulating IL-1β expression through hematopoietic NOD2 signaling.

Alnabhani Z, Montcuquet N, Biaggini K, Dussaillant M, Roy M, Ogier-Denis E, Madi A, Jallane A, Feuilloley M, Hugot JP, Connil N, Barreau F.

Inflamm Bowel Dis. 2015 Mar;21(3):543-55. doi: 10.1097/MIB.0000000000000291.

PMID:
25659087
12.

Role of YopK in Yersinia pseudotuberculosis resistance against polymorphonuclear leukocyte defense.

Thorslund SE, Ermert D, Fahlgren A, Erttmann SF, Nilsson K, Hosseinzadeh A, Urban CF, Fällman M.

Infect Immun. 2013 Jan;81(1):11-22. doi: 10.1128/IAI.00650-12. Epub 2012 Oct 22.

13.
14.

Nod2 regulates the host response towards microflora by modulating T cell function and epithelial permeability in mouse Peyer's patches.

Barreau F, Madre C, Meinzer U, Berrebi D, Dussaillant M, Merlin F, Eckmann L, Karin M, Sterkers G, Bonacorsi S, Lesuffleur T, Hugot JP.

Gut. 2010 Feb;59(2):207-17. doi: 10.1136/gut.2008.171546. Epub 2009 Oct 15.

PMID:
19837677
15.

In vivo-induced InvA-like autotransporters Ifp and InvC of Yersinia pseudotuberculosis promote interactions with intestinal epithelial cells and contribute to virulence.

Pisano F, Kochut A, Uliczka F, Geyer R, Stolz T, Thiermann T, Rohde M, Dersch P.

Infect Immun. 2012 Mar;80(3):1050-64. doi: 10.1128/IAI.05715-11. Epub 2011 Dec 12.

16.
17.

Altered expression of inflammatory cytokine receptors in response to LPS challenge through interaction between intestinal epithelial cells and lymphocytes of Peyer's patch.

Chen J, Ng CP, Tsang LL, Ho LS, Xu PH, Rowlands DK, Gao JY, Chung YW, Li TY, Chan HC.

Cell Biol Int. 2009 Mar;33(3):369-75.

PMID:
19385035
18.

Epithelial Control of Gut-Associated Lymphoid Tissue Formation through p38α-Dependent Restraint of NF-κB Signaling.

Caballero-Franco C, Guma M, Choo MK, Sano Y, Enzler T, Karin M, Mizoguchi A, Park JM.

J Immunol. 2016 Mar 1;196(5):2368-76. doi: 10.4049/jimmunol.1501724. Epub 2016 Jan 20.

19.

Interaction of Yersinia enterocolitica with epithelial cells: invasin beyond invasion.

Grassl GA, Bohn E, Müller Y, Bühler OT, Autenrieth IB.

Int J Med Microbiol. 2003 Apr;293(1):41-54. Review.

PMID:
12755365

Supplemental Content

Support Center